 Twist Bioscience Corporation NASDAQ: TWST has acquired iGenomX, a developer of multiplex library preparation tools for next-generation sequencing workflows, for 35 million. Twist said the acquisition would enhance its ability to support multiplex sequencing preparations across multiple markets and accelerate its conversion of customers from static microarray platforms to genotyping-by-sequencing workflows. 